טוען...
The Antidepressant Agomelatine Improves Memory Deterioration and Upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice
Agomelatine, a novel antidepressant with established clinical efficacy, acts as an agonist of melatonergic MT(1) and MT(2) receptors and as an antagonist of 5-HT(2C) receptors. The present study was undertaken to investigate whether chronic treatment with agomelatine would block unpredictable chroni...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Libertas Academica
2014
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3948735/ https://ncbi.nlm.nih.gov/pubmed/24634580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/DTI.S13870 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|